By Tom Winnifrith | Sunday 1 March 2020
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
I am indeed with my father in Shipston this morning and even he has noticed that he is not quite as rich as he was two weeks ago. Shiuld we pamic about our holdings? On balance I am not suggesting that you do but certain stocks do look very vulnerable. Surely profits warnings from Telit (TCM), IQE (IQE) and Carnival (CCL) are in the pipeline. Then there is the issue of companies such as Bidstack (BIDS) which need placings urgently. Just how possible is that going to be in the current climate. Then to Sirius (SXX). The Sunday papers seem to think that sh\areholders may well reject the Anglo bid and so lose everything. I discuss this looming calamity, who is to blame and what the impact localised and more widely will be.
Already a subscriber? Click here to sign in
This area of the ShareProphets.com site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of ShareProphets.com. ShareProphets.com does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at ShareProphets.com is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by ShareProphets.com and is not intended to be relied upon by users in making (or refraining from making) any investment decisions.
Search ShareProphets |
Stock market news |
Recent Comments |
Site by Everywhen
